Research & Development
Professional, Innovation, and Respect of life
We are a global, new drug developing biopharmaceutical company provide only evidence-based medicine.
Established in 2008, SynCore was cofounded by Sinphar Group and National Health Research Institute (NHRI) Taiwan. We focus on creating values of new drug by R&D management and integration of technology resources. SynCore’s pipeline concentrates on oncology, ophthalmology, and dermatology fields, continuously dedicates in helping patients worldwide.
SynCore’s global phase III clinical trial on pancreatic cancer second-line therapy, [...]
China NMPA Approves SynCore Biotechnology to Conduct Phase III Human Clinical [...]
SynCore Biotechnology (SynCore Bio) is pleased to announce that it will [...]
Topic: 2019 Symposium on Research Development in Dry Age-Related Macular Degeneration [...]